Dihydroartemisinin Alleviates Diclofenac Sodium-Induced Small Intestinal Mucosal Injury by Regulating the MAPK/NF-κB Signaling Pathway and Gut Microbiota Homeostasis
International Journal of Pharmaceutical Investigation · 16.10.2026 · 17 (1) · 362-372
DOI: 10.5530/ijpi.20270229 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Investigation, online erschienen am 16.10.2026. Verfasst von Chun Mei Wang und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, C. M., Shen, B., Xu, C. Y., Zhang, J., Yang, L., Huang, R. Z., & Chen, H. (2026). Dihydroartemisinin Alleviates Diclofenac Sodium-Induced Small Intestinal Mucosal Injury by Regulating the MAPK/NF-κB Signaling Pathway and Gut Microbiota Homeostasis. International Journal of Pharmaceutical Investigation, 17(1), 362-372. https://doi.org/10.5530/ijpi.20270229
Vancouver
Wang CM, Shen B, Xu CY, Zhang J, Yang L, Huang RZ, et al. Dihydroartemisinin Alleviates Diclofenac Sodium-Induced Small Intestinal Mucosal Injury by Regulating the MAPK/NF-κB Signaling Pathway and Gut Microbiota Homeostasis. International Journal of Pharmaceutical Investigation. 2026;17(1):362-372. doi:10.5530/ijpi.20270229
BibTeX
@article{Wang2026,
author = {Wang, Chun Mei and Shen, Bo and Xu, Chen Yan and Zhang, Jing and Yang, Lu and Huang, Ren Zheng and Chen, Hua},
title = {Dihydroartemisinin Alleviates Diclofenac Sodium-Induced Small Intestinal Mucosal Injury by Regulating the MAPK/NF-κB Signaling Pathway and Gut Microbiota Homeostasis},
journal = {International Journal of Pharmaceutical Investigation},
year = {2026},
volume = {17},
number = {1},
pages = {362--372},
doi = {10.5530/ijpi.20270229}
}
EUVIMED